Steven Layton
Payments from drug & device makers
Across 330 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- GSK$967
- Amgen$610
- Boehringer Ingelheim$586
- AbbVie$572
- AstraZeneca$508
- plus $2K from 30 others
What the payments were for
- Food & beverage$6,43799%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 52 | $1,010 |
| GSK | 44 | $967 |
| Amgen | 34 | $610 |
| Boehringer Ingelheim | 26 | $586 |
| AbbVie | 29 | $572 |
| AstraZeneca | 24 | $508 |
| Novartis | 17 | $270 |
| Lilly USA, LLC | 10 | $179 |
| Bayer | 8 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $153 |
| Esperion Therapeutics, Inc. | 9 | $137 |
| Phathom Pharmaceuticals, Inc. | 5 | $129 |
| Amarin Pharma, Inc. | 8 | $127 |
| Paratek Pharmaceuticals, Inc. | 5 | $113 |
| Eisai Inc. | 4 | $93 |
| Abbott | 4 | $87 |
| Jazz Pharmaceuticals Inc. | 4 | $75 |
| Pfizer | 4 | $72 |
| Electromed, Inc. | 5 | $72 |
| Almatica Pharma LLC | 4 | $69 |
| Exact Sciences | 3 | $62 |
| Corcept Therapeutics | 3 | $58 |
| Sanofi-aventis U.S. LLC | 2 | $57 |
| Kowa Pharmaceuticals America, Inc. | 4 | $56 |
| Dexcom, Inc. | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 2 | $31 |
| Medtronic | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $13 |
| Merck | 1 | $12 |
| Vistapharm, Inc. | 1 | $12 |
How this compares
$6,472 in reported general payments places this provider in the 90th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $11,318 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $9,509 |
| Gabapentin | 25 | $581 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $358 |
| Levothyroxine Sodium | 21 | $309 |
| Rosuvastatin Calcium | 31 | $259 |
| Doxycycline Hyclate | 15 | $212 |
| Atorvastatin Calcium | 20 | $191 |
| Omeprazole | 11 | $155 |
| Losartan Potassium | 20 | $152 |
| Methylprednisolone | 18 | $144 |
| Meloxicam | 14 | $120 |
| Alprazolam | 16 | $96 |
| Lisinopril | 19 | $80 |
| Metformin Hcl | 23 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $967 | $11,31814 claims |
| AstraZenecaBreztri Aerosphere | $508 | $9,50912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,031 medical providers in Florida.
Other medical in Tampa
- Sandra SnyderTampa$156K
- Christopher RayTampa$41K
- Kathryn KlossTampa$33K
- Susan FerreyTampa$16K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.